SCHEMBL16617421

SCHEMBL16617421

N#CC(NC(=O)[C@@H]1CCCC[C@H]1c1oc(-c2ccc(F)cc2)nc1-c1ccc(N2CCS(O)(O)CC2)cc1)C1CC1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSK P43235 10/20 0.65
CTSS P25774 3/20 0.40
CTSB P07858 2/20 0.36
KCNH2 Q12809 1/20 0.35
KMT2A Q03164 2/20 0.34
PRCP P42785 1/20 0.33
KDM4E B2RXH2 2/20 0.32
ALDH1A1 P00352 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
HPGD P15428 1/20 0.32
CYP2C19 P33261 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
LMNA P02545 1/20 0.32
TSHR P16473 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
RCE1 Q9Y256 1/20 0.32
HTR3A P46098 2/20 0.32
MAP4K4 O95819 1/20 0.31
TNIK Q9UKE5 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16617701 1.00 CTSK (0.65) CTSKCTSSCTSBKCNH2KMT2A
SCHEMBL16617665 0.98 CTSK (0.67) CTSKCTSSCTSBKCNH2KMT2A
SCHEMBL16617663 0.98 CTSK (0.67) CTSKCTSSCTSBKCNH2KMT2A
SCHEMBL16617709 0.96 CTSK (0.63) CTSKCTSSCTSBKCNH2KMT2A
SCHEMBL16617906 0.96 CTSK (0.63) CTSKCTSSCTSBKCNH2KMT2A
SCHEMBL16617707 0.96 CTSK (0.63) CTSKCTSSCTSBKCNH2KMT2A
SCHEMBL16617702 0.94 CTSK (0.74) CTSKCTSSCTSBKCNH2KMT2A
SCHEMBL16617664 0.92 CTSK (0.75) CTSKCTSSCTSBKCNH2KMT2A
SCHEMBL16617708 0.91 CTSK (0.71) CTSKCTSSCTSBKCNH2KMT2A
SCHEMBL16617909 0.91 CTSK (0.71) CTSKCTSSCTSBKCNH2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9458181-B2 Cathepsin cysteine protease inhibitors MERCK SHARP & DOHME CORP. (US) 2016-10-04 US claimed
US-20150099719-A1 CATHEPSIN CYSTEINE PROTEASE INHIBITORS MERCK SHARP & DOHME LLC 2015-04-09 US claimed
US-9458181-B2 Cathepsin cysteine protease inhibitors MERCK SHARP & DOHME CORP. (US) 2016-10-04 US disclosed
US-20150099719-A1 CATHEPSIN CYSTEINE PROTEASE INHIBITORS MERCK SHARP & DOHME LLC 2015-04-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150099719-A1 CATHEPSIN CYSTEINE PROTEASE INHIBITORS CTSB, CTSS, CTSZ CTSK 4/4885CTSS 2/4885CTSB 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.